27 results on '"Azpiri-Lopez JR"'
Search Results
2. PO.3.59 Echocardiographic abnormalities in systemic lupus erythematosus patients
- Author
-
Guajardo-Jauregui, N, primary, Colunga-Pedraza, IJ, additional, Galarza-Delgado, DA, additional, Azpiri-Lopez, JR, additional, Cardenas-De La Garza, JA, additional, and Lugo-Perez, S, additional
- Published
- 2022
- Full Text
- View/download PDF
3. PO.3.60 Association of left ventricular geometry abnormalities and disease activity in systemic lupus erythematosus patients
- Author
-
Guajardo-Jauregui, N, primary, Azpiri-Lopez, JR, additional, Galarza-Delgado, DA, additional, Colunga-Pedraza, IJ, additional, Cardenas-De La Garza, JA, additional, and Lugo-Perez, S, additional
- Published
- 2022
- Full Text
- View/download PDF
4. PO.3.57 Correlation between disease activity and echocardiographic parameters in systemic lupus erythematosus patients
- Author
-
Guajardo-Jauregui, N, primary, Galarza-Delgado, DA, additional, Colunga-Pedraza, IJ, additional, Azpiri-Lopez, JR, additional, Cardenas-De La Garza, JA, additional, and Lugo-Perez, S, additional
- Published
- 2022
- Full Text
- View/download PDF
5. PO.3.58 Association of anti-double stranded dna antibody titers and echocardiographic parameters in systemic lupus erythematosus patients
- Author
-
Guajardo-Jauregui, N, primary, Colunga-Pedraza, IJ, additional, Galarza-Delgado, DA, additional, Azpiri-Lopez, JR, additional, Cardenas-De La Garza, JA, additional, and Lugo-Perez, S, additional
- Published
- 2022
- Full Text
- View/download PDF
6. AB0205 Carotid intima-media thickness linked to the presence of cardiovascular risk factors in mexican mestizo patients with rheumatoid arthritis
- Author
-
Galarza-Delgado, DA, primary, Azpiri-Lopez, JR, additional, Colunga-Pedraza, IJ, additional, Ramos-Cazares, RE, additional, Torres-Quintanilla, FJ, additional, Valdovinos-Bañuelos, A, additional, Arvizu-Rivera, RI, additional, Martinez-Moreno, A, additional, Garza, JA Cardenas-de la, additional, Garcia-Colunga, JI, additional, and Elizondo-Riojas, G, additional
- Published
- 2017
- Full Text
- View/download PDF
7. AB0204 Disease factors associated to abnormal intima-media thickness in mexican mestizo rheumatoid arthritis patients
- Author
-
Galarza-Delgado, DA, primary, Azpiri-Lopez, JR, additional, Colunga-Pedraza, IJ, additional, Ramos-Cazares, RE, additional, Torres-Quintanilla, FJ, additional, Valdovinos-Bañuelos, A, additional, Arvizu-Rivera, RI, additional, Martinez-Moreno, A, additional, Garza, JA Cardenas-de la, additional, Vera-Pineda, R, additional, Elizondo-Riojas, G, additional, and Garcia-Colunga, JI, additional
- Published
- 2017
- Full Text
- View/download PDF
8. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis.
- Author
-
Karpouzas GA, Ormseth SR, van Riel PLCM, Gonzalez-Gay MA, Corrales A, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Tsang L, Hitchon C, El-Gabalawy H, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, Misra DP, Hauge EM, and Kitas G
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Biomarkers, C-Reactive Protein metabolism, C-Reactive Protein analysis, Risk Factors, Severity of Illness Index, Arthritis, Rheumatoid complications, Arthritis, Rheumatoid drug therapy, Antirheumatic Agents therapeutic use, Antirheumatic Agents adverse effects, Cardiovascular Diseases etiology, Cardiovascular Diseases epidemiology, Cardiovascular Diseases mortality, Inflammation
- Abstract
Objectives: Chronic inflammation promotes cardiovascular risk in rheumatoid arthritis (RA). Biological disease-modifying antirheumatic drugs (bDMARDs) improve disease activity and cardiovascular disease outcomes. We explored whether bDMARDs influence the impact of disease activity and inflammatory markers on long-term cardiovascular risk in RA., Methods: We studied 4370 participants without cardiovascular disease in a 10-country observational cohort of patients with RA. Endpoints were (1) major adverse cardiovascular events (MACE) encompassing myocardial infarction, stroke and cardiovascular death; and (2) any ischaemic cardiovascular events (iCVE) including MACE plus revascularisation, angina, transient ischaemic attack and peripheral arterial disease., Results: Over 26 534 patient-years, 239 MACE and 362 iCVE occurred. The interaction between 28-joint Disease Activity Score with C-reactive protein (DAS28-CRP) and bDMARD use was significant for MACE (p=0.017), suggesting the effect of DAS28-CRP on MACE risk differed among bDMARD users (n=515) and non-users (n=3855). DAS28-CRP (per unit increase) is associated with MACE risk in bDMARD non-users (HR 1.21 (95% CI 1.07 to 1.37)) but not users (HR 0.69 (95% CI 0.40 to 1.20)). The interaction between CRP (per log unit increase) and bDMARD use was also significant for MACE (p=0.011). CRP associated with MACE risk in bDMARD non-users (HR 1.16 (95% CI 1.04 to 1.30)), but not users (HR 0.65 (95% CI 0.36 to 1.17)). No interaction was observed between bDMARD use and DAS28-CRP (p=0.167) or CRP (p=0.237) for iCVE risk., Conclusions: RA activity and inflammatory markers associated with risk of MACE in bDMARD non-users but not users suggesting the possibility of biological-specific benefits locally on arterial wall independently of effects on systemic inflammation., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
9. Obesity is associated with higher nail psoriasis disease activity and prevalence in patients with psoriatic arthritis.
- Author
-
Galarza-Delgado DA, Azpiri-Lopez JR, Flores-Alvarado DE, Guajardo-Jauregui N, Cardenas-de la Garza JA, Arvizu-Rivera RI, Gonzalez-Gonzalez V, Reyes-Soto MA, and Colunga-Pedraza IJ
- Subjects
- Humans, Prevalence, Obesity complications, Obesity epidemiology, Nails, Arthritis, Psoriatic complications, Arthritis, Psoriatic epidemiology, Psoriasis complications, Psoriasis epidemiology, Nail Diseases etiology, Nail Diseases complications
- Published
- 2024
- Full Text
- View/download PDF
10. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
- Author
-
Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Gonzalez-Gonzalez V, Beltran-Aguilar VM, Arias-Peralta AG, De Avila-Gonzalez N, and Guajardo-Jauregui N
- Subjects
- Humans, Pandemics, Communicable Disease Control, COVID-19 epidemiology, Cardiovascular Diseases complications, Cardiovascular Diseases epidemiology, Autoimmune Diseases complications, Autoimmune Diseases epidemiology, Autoimmune Diseases drug therapy, Rheumatic Diseases complications, Rheumatic Diseases epidemiology, Rheumatic Diseases drug therapy, Arthritis, Rheumatoid drug therapy, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic epidemiology, Lupus Erythematosus, Systemic drug therapy
- Abstract
Rheumatic autoimmune diseases are associated with a myriad of comorbidities. Of particular importance due to their morbimortality are cardiovascular diseases. COVID-19 greatly impacted the world population in many different areas. Patients with rheumatic diseases had to face changes in their healthcare, in addition to unemployment, a decrease in physical activity, social isolation, and lack of access to certain medications. This review summarizes the impact of COVID-19 pandemic on cardiovascular risk factors, comorbidities, and unhealthy behaviors in patients with rheumatic inflammatory autoimmune diseases, particularly focused on rheumatoid arthritis and systemic lupus erythematosus. Searches were carried out in MEDLINE/PubMed and Scopus from August to December 2022. Four reviewers screened the title and abstract of retrieved records. Potentially eligible reports were then reviewed in full text. Differences were reconciled by either consensus or discussion with an external reviewer. During the COVID-19 pandemic, patients with rheumatic diseases showed an increase in the prevalence of mental health disorders (43.2-57.7%), reduced physical activity (56.8%), and a worsening in eating behaviors. Alcohol intake increased (18.2%), especially in early phases of the pandemic. Smoking prevalence decreased (28.2%). Dyslipidemia and hypertension showed no changes. The pandemic and lockdown affected rheumatic patients not only in disease-related characteristics but in the prevalence of their cardiovascular comorbidities and risk factors. Lifestyle changes, such as healthy eating, physical activity, and optimal management of their rheumatic diseases and comorbidities, are essential to manage the long-lasting consequences of the COVID-19 outbreak. Key Points • During the COVID-19 pandemic, anxiety, depression, sedentarism, obesity, and a worsening in eating behaviors increased. •Patients with rheumatic diseases and comorbidities have worse clinical outcomes and a higher cardiovascular disease burden than those without them. •Comparative studies are necessary to precisely elucidate the pandemic's impact on the prevalence of cardiovascular disease, risk factors, and comorbidities in patients with rheumatoid arthritis and systemic lupus erythematosus., (© 2023. International League of Associations for Rheumatology (ILAR).)
- Published
- 2023
- Full Text
- View/download PDF
11. Carotid atherosclerosis in the first five years since rheumatoid arthritis diagnosis: a cross sectional study.
- Author
-
Galarza-Delgado DA, Azpiri-Lopez JR, Guajardo-Jauregui N, Cardenas-de la Garza JA, Garza-Cisneros AN, Garcia-Heredia A, Balderas-Palacios MA, and Colunga-Pedraza IJ
- Subjects
- Humans, Cross-Sectional Studies, Carotid Intima-Media Thickness, Risk Factors, Arthritis, Rheumatoid complications, Arthritis, Rheumatoid diagnosis, Arthritis, Rheumatoid epidemiology, Carotid Artery Diseases diagnostic imaging, Carotid Artery Diseases epidemiology, Atherosclerosis diagnosis, Atherosclerosis epidemiology
- Abstract
Background: Systemic inflammation, documented before rheumatoid arthritis (RA) diagnosis, is associated with accelerated atherosclerosis. We aimed to compare the prevalence of carotid plaque (CP) in RA patients in the first five years since diagnosis and healthy controls, and to determine disease characteristics associated with the presence of subclinical atherosclerosis in RA patients., Methods: This was a cross-sectional study. We recruited 60 RA patients in the first five years since diagnosis and 60 matched healthy controls. Carotid ultrasound was performed to detect the presence of CP and measure carotid-intima media thickness (cIMT). Subclinical atherosclerosis was considered as the presence of CP and/or increased cIMT. Distribution was evaluated with the Kolmogorov-Smirnov test. Comparisons were made with Chi-square or Fisher's exact test for qualitative variables and Student's t or Mann-Whitney's U test for quantitative variables. A p-value < 0.05 was considered significant., Results: There were no differences in the demographic characteristics between RA patients and controls. The mean disease duration was 2.66 ± 1.39 years. A higher prevalence of CP (30.0% vs. 11.7%, p = 0.013), bilateral CP (18.3% vs. 3.3%, p = 0.008), increased cIMT (30.0% vs. 6.7%, p = 0.001), and subclinical atherosclerosis (53.3% vs. 18.3%, p = < 0.001) was found in RA patients. RA patients with subclinical atherosclerosis were older (56.70 years vs. 50.00 years, p = 0.002), presented a higher prevalence of dyslipidemia (53.1% vs. 14.3%, p = 0.002), and higher prevalence of classification in moderate-high disease activity category measured by DAS28-CRP (68.8% vs. 35.7%, p = 0.010). The latter variable persisted independently associated with subclinical atherosclerosis in the binary logistic regression (OR 6.11, 95% CI 1.51-24.70, p = 0.011)., Conclusions: In the first five years since diagnosis, higher prevalence of subclinical atherosclerosis, including CP was found in RA patients. Carotid ultrasound should be considered part of the systematic CVR evaluation of RA at the time of diagnosis., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
12. Association of soluble cell adhesion molecules and lipid levels in rheumatoid arthritis patients.
- Author
-
Colunga-Pedraza IJ, Galarza-Delgado DA, Guajardo-Jauregui N, Cardenas-de la Garza JA, Garcia-Arellano G, Arvizu-Rivera RI, Garza-Cisneros AN, Garcia-Heredia A, Balderas-Palacios MA, and Azpiri-Lopez JR
- Subjects
- Humans, Cross-Sectional Studies, Cell Adhesion Molecules, C-Reactive Protein analysis, Lipids, Vascular Cell Adhesion Molecule-1, Intercellular Adhesion Molecule-1, Arthritis, Rheumatoid drug therapy
- Abstract
Objectives: To evaluate the relationship between soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intracellular adhesion molecule-1 (sICAM-1), and lipid levels in rheumatoid arthritis (RA) patients with and without carotid plaque (CP)., Methods: Cross-sectional study nested of a RA cohort. RA patients without a previous cardiovascular event or statins' therapy, aged 40-75 years were recruited at an outpatient cardio-rheumatology clinic. Carotid ultrasound was performed in all study subjects. RA patients with CP were included and matched to RA patients without CP by age, gender, and traditional cardiovascular risk factors. Blood samples were drawn at the time of recruitment to measure sVCAM-1, sICAM-1, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and lipid levels. Correlations between cell adhesion molecules, disease activity indexes, ESR and CRP with lipid levels were assessed with Spearman's correlation coefficient (rs)., Results: We included 71 RA patients, 37 with CP and 34 without CP. RA (n = 71) patients had a moderate negative correlation of sVCAM-1 with total cholesterol (TC) (rs = - 0.366, p = 0.002) and low-density lipoprotein (LDL) (rs = - 0.316, p = 0.007), and a small negative correlation with high-density lipoprotein (rs = - 0.250, p = 0.036). ESR showed a small negative correlation with LDL (rs = - 0.247, p = 0.038). Patients with CP had a moderate negative correlation between sVCAM and TC (rs = - 0.405, p = 0.013). Patients without CP showed a moderate negative correlation between sVCAM with TC (rs = - 0.364, p = 0.034) and LDL (rs = - 0.352, p = 0.041), and sICAM with VLDL (rs = - 0.343, p = 0.047)., Conclusions: RA patients showed an inverse association of sVCAM-1 and lipid levels. More studies are needed to define the precise role of sVCAM-1 in the lipid paradox of RA., (© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).)
- Published
- 2023
- Full Text
- View/download PDF
13. Subclinical systolic dysfunction by speckle tracking echocardiography in patients with systemic lupus erythematosus.
- Author
-
Azpiri-Lopez JR, Galarza-Delgado DA, Garza-Cisneros AN, Guajardo-Jauregui N, Balderas-Palacios MA, Garcia-Heredia A, Cardenas-de la Garza JA, Rodriguez-Romero AB, Reyna-de la Garza RA, Azpiri-Diaz H, Alonso-Cepeda O, and Colunga-Pedraza IJ
- Subjects
- Adolescent, Cross-Sectional Studies, Echocardiography, Humans, Male, Obesity complications, Stroke Volume, Ventricular Function, Left, Cardiomyopathies, Hypertension complications, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic diagnosis, Lupus Erythematosus, Systemic epidemiology, Ventricular Dysfunction, Left diagnostic imaging, Ventricular Dysfunction, Left epidemiology, Ventricular Dysfunction, Left etiology
- Abstract
Background: We aimed to compare the prevalence of subclinical left ventricular systolic dysfunction in Hispanic systemic lupus erythematosus (SLE) patients versus healthy controls., Material and Methods: This cross-sectional study included 46 SLE patients who fulfilled the 2019 European League Against Rheumatism and American College of Rheumatology (EULAR/ACR) classification criteria for SLE and with age ≥ 18 years. For comparison, we included a control group with 46 non-SLE subjects matched by age (±5 years) and gender. A transthoracic echocardiogram was performed on every participant. The echocardiographic measurements evaluated were left ventricular ejection fraction (LVEF), relative wall thickness (RWT), and tricuspid annular plane systolic excursion (TAPSE). Left ventricular-Global Longitudinal Strain (GLS) was evaluated, and a value higher than -18% was classified as subclinical left ventricular systolic dysfunction. Comparisons between groups were made using the Chi-square test or Fisher's exact test for qualitative variables, and Student's t-test or the Mann-Whitney's U test for quantitative variables. A p-value <.05 was considered significant., Results: We found a significant difference in the presence of subclinical left ventricular systolic dysfunction between SLE-patients and controls (37.0% vs 8.7%, p = .001). We also found that SLE patients had a lower left ventricular GLS (-18.90% vs -20.51%, p = .011), TAPSE (21.63 mm vs 23.60 mm, p = .009), and LVEF (57.17% vs 62.47%, p = <.001) than controls. Systemic lupus erythematosus diagnosis was independently associated with the presence of subclinical left ventricular systolic dysfunction with an OR of 6.068 (CI 95% 1.675-21.987) ( p = .006). Subclinical systolic dysfunction was more common in men (29.4% vs 3.4%, p = .020), patients with obesity (17.6% vs 0%, p = .045), or hypertension (47.1% vs 6.9%, p = .001)., Conclusion: Systemic lupus erythematosus Hispanic patients had a higher prevalence of subclinical left ventricular systolic dysfunction, and worse left ventricular GLS, LVEF, and TAPSE values than matched healthy controls. Additionally, we found that male gender, obesity, and hypertension are associated with the presence of subclinical left ventricular systolic dysfunction in SLE patients. The inclusion of speckle tracking echocardiography as part of the cardiovascular evaluation of SLE patients may help identify high cardiovascular risk patients.
- Published
- 2022
- Full Text
- View/download PDF
14. Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients.
- Author
-
Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Guajardo-Jauregui N, Rodriguez-Romero AB, Lugo-Perez S, Cardenas-de la Garza JA, Arvizu-Rivera RI, Flores-Alvarado DE, Ilizaliturri-Guerra O, Garcia-Arellano G, and Garza-Acosta AC
- Subjects
- Algorithms, Carotid Intima-Media Thickness, Cross-Sectional Studies, Heart Disease Risk Factors, Humans, Lipids, Risk Assessment, Risk Factors, Arthritis, Psoriatic complications, Arthritis, Psoriatic diagnostic imaging, Arthritis, Psoriatic epidemiology, Atherosclerosis epidemiology, Cardiovascular Diseases diagnostic imaging, Cardiovascular Diseases epidemiology, Plaque, Atherosclerotic
- Abstract
The objective was to compare the prevalence of subclinical atherosclerosis and cardiovascular risk (CVR) reclassification using six CVR algorithms and a carotid ultrasound in psoriatic arthritis (PsA) patients and controls. The method was cross-sectional study. A total of 81 patients aged 40-75 years, who fulfilled the 2006 CASPAR criteria and 81 controls matched by age, gender, and comorbidities were recruited. CVR was evaluated according to six CVR algorithms, including Framingham Risk Score (FRS)-lipids, FRS-body mass index (BMI), Atherosclerotic Cardiovascular Disease (ASCVD) Algorithm, Systematic Coronary Risk Evaluation (SCORE), QRISK3, and Reynolds Risk Score (RRS). A carotid ultrasound was performed to identify the presence of carotid plaque (CP) defined as a carotid intima media thickness ≥ 1.2 mm or a focal narrowing of the surrounding lumen ≥ 0.5mm. Patients with presence of CP, classified in the low-moderate risk by the CVR algorithms, were reclassified to a higher risk category. CP was more prevalent in PsA patients (44.4% vs 24.7%, p = 0.008), as was subclinical atherosclerosis (51.9% vs 33.3%, p = 0.017). When comparing the CVR reclassification to a higher risk category, a difference was found in the six CVR algorithms. The reclassification was more prevalent in PsA patients: 30.8% vs 12.3%, p = 0.004 with FRS-lipids; 28.4% vs 9.9%, p = 0.003 with FRS-BMI; 40.7% vs 19.8%, p = 0.003 with SCORE; 30.9% vs 16.0%, p = 0.026 with ASCVD algorithm; 37.0% vs 19.8%, p = 0.015 with RRS; and 33.3% vs 16.0%, p = 0.011 with QRISK3. The CVR algorithms underestimate the actual CVR of PsA patients. A carotid ultrasound should be considered as part of the CVR evaluation of PsA patients. KEY POINTS: • Subclinical atherosclerosis was more prevalent in psoriatic arthritis patients than controls. • Cardiovascular risk reclassification, through a carotid ultrasound, according to traditional cardiovascular risk algorithms was more common in psoriatic arthritis patients. • The cardiovascular risk algorithm that showed the lowest reclassification rate in psoriatic arthritis patients was the FRS-BMI. • All cardiovascular risk algorithms underestimate the actual risk of psoriatic arthritis patients, preventing the initiation of an adequate cardiovascular treatment., (© 2021. International League of Associations for Rheumatology (ILAR).)
- Published
- 2022
- Full Text
- View/download PDF
15. Statin indication according to the 2019 World Health Organization cardiovascular disease risk charts and carotid ultrasound in Mexican mestizo rheumatoid arthritis patients.
- Author
-
Galarza-Delgado DA, Colunga-Pedraza IJ, Azpiri-Lopez JR, Guajardo-Jauregui N, Rodriguez-Romero AB, Loya-Acosta J, Meza-Garza A, Cardenas-de la Garza JA, Lugo-Perez S, and Castillo-Treviño JN
- Subjects
- Carotid Intima-Media Thickness, Cross-Sectional Studies, Humans, World Health Organization, Arthritis, Rheumatoid complications, Arthritis, Rheumatoid diagnostic imaging, Arthritis, Rheumatoid drug therapy, Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
- Abstract
Background: We aimed to assess the concordance of recommendation for initiating statin therapy according to the 2019 World Health Organization (WHO) cardiovascular disease (CVD) risk charts and to the presence of carotid plaque (CP) identified with carotid ultrasound in Mexican mestizo rheumatoid arthritis (RA) patients, and to determine the proportion of patients reclassified to a high cardiovascular risk after the carotid ultrasound was performed., Methods: This was a cross-sectional study nested of a RA patients' cohort. A total of 157 Mexican mestizo RA patients were included. The cardiovascular evaluation was performed using the 2019 WHO CVD risk charts (laboratory-based model) for the Central Latin America region. A carotid ultrasound was performed in all patients. The indication to start statin therapy was considered if the patient was classified as high risk, moderate risk if > 40 years with total cholesterol (TC) > 200 mg/dl or LDL-C > 120 mg/dl, and low risk if > 40 years with TC > 300 mg/dl, according to the WHO CVD risk chart or if the patient had carotid plaque (CP). Cohen's kappa (k) coefficient was used to evaluate the concordance between statin therapy initiation., Results: Initiation of statin therapy was considered in 49 (31.2%) patients according to the 2019 WHO CVD risk charts and 49 (31.2%) patients by the presence of CP. Cardiovascular risk reclassification by the presence of CP was observed in 29 (18.9%) patients. A slight agreement (k = 0.140) was observed when comparing statin therapy recommendations between 2019 WHO CVD risk charts and the presence of CP., Conclusion: The WHO CVD risk charts failed to identify a large proportion of patients with subclinical atherosclerosis detected by the carotid ultrasound and the concordance between both methods was poor. Therefore, carotid ultrasound should be considered in the cardiovascular evaluation of RA patients., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
16. Nail involvement in psoriatic arthritis patients is an independent risk factor for carotid plaque.
- Author
-
Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Rodriguez-Romero AB, Guajardo-Jauregui N, Cardenas-de la Garza JA, Lugo-Perez S, Meza-Garza A, Loya-Acosta J, and Garza-Acosta AC
- Subjects
- Adult, Aged, Carotid Artery Diseases diagnostic imaging, Carotid Intima-Media Thickness, Case-Control Studies, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Plaque, Atherosclerotic diagnostic imaging, Risk Factors, Arthritis, Psoriatic epidemiology, Carotid Artery Diseases epidemiology, Nail Diseases epidemiology, Plaque, Atherosclerotic epidemiology
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2021
- Full Text
- View/download PDF
17. Carotid Plaque Is Not Associated With Increased Levels of Interleukin 1, Interleukin 6, and Tumor Necrosis Factor α in Rheumatoid Arthritis.
- Author
-
Arvizu-Rivera RI, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Garcia-Arellano G, Martinez-Moreno A, Abundis-Marquez EE, and Galarza-Delgado DA
- Subjects
- Carotid Arteries, Humans, Arthritis, Rheumatoid diagnosis, Carotid Stenosis, Interleukin-1, Interleukin-6, Tumor Necrosis Factor-alpha
- Abstract
Competing Interests: The authors declare no conflict of interest.
- Published
- 2021
- Full Text
- View/download PDF
18. Echocardiographic evaluation of pulmonary hypertension, right ventricular function, and right ventricular-pulmonary arterial coupling in patients with rheumatoid arthritis.
- Author
-
Azpiri-Lopez JR, Galarza-Delgado DA, Colunga-Pedraza IJ, Arvizu-Rivera RI, Cardenas-de la Garza JA, Vera-Pineda R, Davila-Jimenez JA, Martinez-Flores CM, Rodriguez-Romero AB, and Guajardo-Jauregui N
- Subjects
- Case-Control Studies, Echocardiography, Heart Ventricles diagnostic imaging, Humans, Pulmonary Artery diagnostic imaging, Stroke Volume, Ventricular Function, Right, Arthritis, Rheumatoid complications, Arthritis, Rheumatoid diagnostic imaging, Hypertension, Pulmonary complications, Hypertension, Pulmonary diagnostic imaging, Ventricular Dysfunction, Right diagnostic imaging
- Abstract
Introduction: Rheumatoid arthritis (RA) patients are at increased risk for developing cardiovascular disease, including right heart failure. The evaluation of right ventricle (RV) using the relationship between tricuspid annular plane systolic excursion (TAPSE) and right ventricular systolic pressure (RVSP) is of clinical prognostic relevance. Mild echocardiographic pulmonary hypertension (ePH) has been associated with worse RV function. The aim of this study was to evaluate RV function as measured by TAPSE to RVSP ratio in rheumatoid arthritis patients compared to matched healthy controls., Method: A case-control study with 67 RA patients aged 40 to 75 years that fulfilled the 2010 ACR/EULAR criteria and 45 matching controls was included. A transthoracic echocardiogram was performed to all patients. TAPSE was measured as the distance traveled from end-diastole to end-systole. RVSP was calculated using the modified Bernoulli equation. Comparisons were done using Chi-square and Mann-Whitney's U test or Student's t test., Results: Patients with RA had significantly reduced ventricular function (TAPSE 23 [21-25] vs 25 [23-26], p = 0.033) and TAPSE/RVSP ratio was significantly lower in RA-patients than controls (TAPSE to RVSP ratio 0.809 [0.67-1.01] vs 0.933 [0.79-1.11], p = 0.009). RA-patients with mild ePH had similar RV function, evaluated by TAPSE, in comparison to RA-patients with normal RVSP., Conclusion: RA-patients had worse RV function measured by TAPSE and worse TAPSE/RVSP ratio than controls. Also, RA-patients with mild ePH had reduced right ventricular-pulmonary arterial coupling in comparison with patients with RA and normal RVSP. These echocardiographic findings could justify aggressive treatment for these patients and assess their evolution. Key Points • Right ventricular (RV) function and RV coupling with the pulmonary artery (RV-PA coupling) were worse in patients with RA in comparison to healthy controls. • Values of right ventricular systolic pressure (RVSP) were similar between RA-patients and non-RA controls. • Prevalence of normal RVSP, mild echocardiographic pulmonary hypertension (ePH), and pulmonary hypertension was similar between RA-patients and non-RA matched controls •Patients with RA and mild ePH had reduced RV-PA coupling in comparison with RA-patients with normal RVSP.
- Published
- 2021
- Full Text
- View/download PDF
19. Improvement of electrocardiographic diagnostic accuracy of left ventricular hypertrophy using a Machine Learning approach.
- Author
-
De la Garza-Salazar F, Romero-Ibarguengoitia ME, Rodriguez-Diaz EA, Azpiri-Lopez JR, and González-Cantu A
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Electrocardiography methods, Hypertrophy, Left Ventricular diagnosis, Machine Learning
- Abstract
The electrocardiogram (ECG) is the most common tool used to predict left ventricular hypertrophy (LVH). However, it is limited by its low accuracy (<60%) and sensitivity (30%). We set forth the hypothesis that the Machine Learning (ML) C5.0 algorithm could optimize the ECG in the prediction of LVH by echocardiography (Echo) while also establishing ECG-LVH phenotypes. We used Echo as the standard diagnostic tool to detect LVH and measured the ECG abnormalities found in Echo-LVH. We included 432 patients (power = 99%). Of these, 202 patients (46.7%) had Echo-LVH and 240 (55.6%) were males. We included a wide range of ventricular masses and Echo-LVH severities which were classified as mild (n = 77, 38.1%), moderate (n = 50, 24.7%) and severe (n = 75, 37.1%). Data was divided into a training/testing set (80%/20%) and we applied logistic regression analysis on the ECG measurements. The logistic regression model with the best ability to identify Echo-LVH was introduced into the C5.0 ML algorithm. We created multiple decision trees and selected the tree with the highest performance. The resultant five-level binary decision tree used only six predictive variables and had an accuracy of 71.4% (95%CI, 65.5-80.2), a sensitivity of 79.6%, specificity of 53%, positive predictive value of 66.6% and a negative predictive value of 69.3%. Internal validation reached a mean accuracy of 71.4% (64.4-78.5). Our results were reproduced in a second validation group and a similar diagnostic accuracy was obtained, 73.3% (95%CI, 65.5-80.2), sensitivity (81.6%), specificity (69.3%), positive predictive value (56.3%) and negative predictive value (88.6%). We calculated the Romhilt-Estes multilevel score and compared it to our model. The accuracy of the Romhilt-Estes system had an accuracy of 61.3% (CI95%, 56.5-65.9), a sensitivity of 23.2% and a specificity of 94.8% with similar results in the external validation group. In conclusion, the C5.0 ML algorithm surpassed the accuracy of current ECG criteria in the detection of Echo-LVH. Our new criteria hinge on ECG abnormalities that identify high-risk patients and provide some insight on electrogenesis in Echo-LVH., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
20. Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age models.
- Author
-
Wibetoe G, Sexton J, Ikdahl E, Rollefstad S, Kitas GD, van Riel P, Gabriel S, Kvien TK, Douglas K, Sandoo A, Arts EE, Wållberg-Jonsson S, Dahlqvist SR, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon CA, Pascual-Ramos V, Contreas-Yañes I, Sfikakis PP, González-Gay MA, Colunga-Pedraz IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Crowson CS, and Semb AG
- Subjects
- Adult, Age Factors, Aged, Female, Humans, Male, Middle Aged, Risk Assessment methods, Risk Factors, Arthritis, Rheumatoid complications, Cardiovascular Diseases epidemiology
- Abstract
Background: In younger individuals, low absolute risk of cardiovascular disease (CVD) may conceal an increased risk age and relative risk of CVD. Calculation of risk age is proposed as an adjuvant to absolute CVD risk estimation in European guidelines. We aimed to compare the discriminative ability of available risk age models in prediction of CVD in rheumatoid arthritis (RA). Secondly, we also evaluated the performance of risk age models in subgroups based on RA disease characteristics., Methods: RA patients aged 30-70 years were included from an international consortium named A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Prior CVD and diabetes mellitus were exclusion criteria. The discriminatory ability of specific risk age models was evaluated using c-statistics and their standard errors after calculating time until fatal or non-fatal CVD or last follow-up., Results: A total of 1974 patients were included in the main analyses, and 144 events were observed during follow-up, the median follow-up being 5.0 years. The risk age models gave highly correlated results, demonstrating R
2 values ranging from 0.87 to 0.97. However, risk age estimations differed > 5 years in 15-32% of patients. C-statistics ranged 0.68-0.72 with standard errors of approximately 0.03. Despite certain RA characteristics being associated with low c-indices, standard errors were high. Restricting analysis to European RA patients yielded similar results., Conclusions: The cardiovascular risk age and vascular age models have comparable performance in predicting CVD in RA patients. The influence of RA disease characteristics on the predictive ability of these prediction models remains inconclusive.- Published
- 2020
- Full Text
- View/download PDF
21. Carotid ultrasound findings in rheumatoid arthritis and control subjects: A case-control study.
- Author
-
Wah-Suarez MI, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Abundis-Marquez EE, Davila-Jimenez JA, Guillen-Gutierrez CY, and Elizondo-Riojas G
- Subjects
- Adult, Aged, Arthritis, Rheumatoid ethnology, Arthritis, Rheumatoid pathology, Asymptomatic Diseases, Carotid Arteries pathology, Carotid Artery Diseases ethnology, Carotid Artery Diseases pathology, Case-Control Studies, Cross-Sectional Studies, Female, Humans, Incidence, Indians, North American, Male, Mexico, Middle Aged, Plaque, Atherosclerotic, Predictive Value of Tests, Prevalence, Prospective Studies, Risk Factors, Arthritis, Rheumatoid diagnostic imaging, Carotid Arteries diagnostic imaging, Carotid Artery Diseases diagnostic imaging, Carotid Intima-Media Thickness, Ultrasonography, Doppler, Color
- Abstract
Rheumatoid arthritis (RA) is a chronic, inflammatory disease closely linked with atherosclerosis. Recommended cardiovascular disease (CVD) integral evaluation includes screening for asymptomatic atherosclerosis plaques with carotid ultrasound (US). The aim of this study is to evaluate the carotid US characteristics, including carotid intima media thickness (cIMT) and carotid plaque (CP), and compare RA-patients and controls in a Mexican-mestizo population., Method: Prospective cross-sectional, observational study comparing RA-patients and matched controls without RA. Medical history and physical exam was performed in all subjects by a rheumatologist and two clinical blinded radiologists did the carotid US. Increased cIMT was defined as ≥0.9 mm. CP was defined as a focal narrowing ≥0.5 mm of the surrounding lumen or a cIMT ≥1.2 mm. Multivariable analysis was done comparing RA-patients and control subjects characteristics with carotid US., Result: In the final analysis 209 patients were included, 103 patients with RA and 106 controls. Bilateral CP was found more than twice in RA than controls (15.5% vs 6.6%). Unilateral CP was more common in either side evaluated, being heterogeneous plaques the most common in RA-patients. The prevalence of increased cIMT was found higher in RA-patients either in both sides (right 37.9% vs 15.1%, P = 0.00; left 43.7% vs 19.8%, P = 0.00) were statistically significant., Conclusion: It was confirmed that RA-patients have greater subclinical atherosclerosis represented in the carotid US measuring cIMT and CP as surrogates. RA-patients with subclinical atherosclerotic disease have more heterogeneous plaques characteristics., (© 2018 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
22. The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients.
- Author
-
Wah-Suarez MI, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Arvizu-Rivera RI, Martinez-Moreno A, Ramos-Cazares RE, Abundis-Marquez EE, Guillen-Lozoya AH, Davila-Jimenez JA, Guillen-Gutierrez CY, and Elizondo-Riojas G
- Subjects
- Adult, Aged, Body Mass Index, Cardiovascular Diseases etiology, Carotid Artery Diseases etiology, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Humans, Lipids blood, Male, Middle Aged, Risk Factors, Arthritis, Rheumatoid complications, Carotid Artery Diseases diagnostic imaging, Carotid Intima-Media Thickness
- Abstract
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in patients with rheumatoid arthritis (RA). Chronic inflammation and traditional risk factors increase cardiovascular risk (CVR) in these patients. Several CVR calculators are used in general population and in RA patients to predict cardiovascular outcomes and tailor therapy but the precision of these calculators in RA patients has yet to be determined. The aim of this study is to determine which risk calculator correlates best with carotid ultrasound (US) findings, specifically carotid plaque (CP) and carotid intima-media thickness (CIMT) in RA patients without clinical manifestations. This was a cross-sectional observational study relating CVR scores in RA patients with the presence of carotid US findings. A total of 97 patients 40 to 75 years old who fulfilled the 2010 ACR/EULAR and/or the 1987 ACR classification criteria for RA were selected. Clinical assessment of cardiovascular risk was performed using seven calculators and carotid US measurement of intima-media thickness and plaque. The tests with the highest sensitivity for CIMT were the Framingham BMI, Framingham lipids, ACC/AHA 2013, and QRISK2. In CP, the highest sensitivity was in QRISK2, SCORE, and ACC/AHA 2013. RA patients should be comprehensively evaluated to detect cardiovascular risk. Carotid US may be routinely recommended to detect subclinical atherosclerosis in RA patients. A lower cutoff point in CVR scales may be necessary to identify patients with a low and intermediate CVR to detect subclinical atherosclerosis earlier and personalize therapy.
- Published
- 2018
- Full Text
- View/download PDF
23. Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.
- Author
-
Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cárdenas-de la Garza JA, Vera-Pineda R, Wah-Suárez M, Arvizu-Rivera RI, Martínez-Moreno A, Ramos-Cázares RE, Torres-Quintanilla FJ, Valdovinos-Bañuelos A, Esquivel-Valerio JA, and Garza-Elizondo MA
- Subjects
- Adult, Aged, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid diagnosis, Arthritis, Rheumatoid drug therapy, Comorbidity, Cross-Sectional Studies, Female, Humans, Male, Mexico epidemiology, Middle Aged, Prevalence, Prognosis, Prospective Studies, Risk Factors, Time Factors, Arthritis, Rheumatoid ethnology, Indians, North American
- Abstract
Patients with rheumatoid arthritis (RA) have a high risk for comorbid conditions which increase mortality, hospital admissions, costs of care and inability. To evaluate the prevalence of comorbidities in Mexican mestizo patients with RA and determine the associated risk factors. Cross-sectional study in which RA patients admitted to our outpatient clinic were consecutively enrolled. We collected data regarding demographics, disease characteristics and comorbidities at the time of the patient's visit to the clinic. We analyzed 225 patients. Their mean age was 55.7 ± 8.3 years; disease duration, 9.5 (3.8-15.5) years; female gender, 93.8%; Disease Activity Score using 28 joints-C-reactive protein, 3 (2-4); methotrexate use, 84.9%; use of any other conventional disease modifying anti-rheumatic drug, 65.7%; use of biological agents, 8%. The most frequently associated diseases were: hypertension, 29.8%; dyslipidemia, 27.1%; osteoporosis, 19.1%; diabetes, 12.4%; hypothyroidism, 6.2%; solid malignancies 4.4%. Risk factors were also evaluated, the most prevalent was overweight in 101 (44.9%) of our patients. A total of 71 (31.6%) had obesity. We also detected high blood pressure in 12.4%, hyperglycemia in 27.1% and hyperlipidemia in 49.8%. Due to the high frequency of comorbidities among RA patients, it is important to follow existing recommendations for their timely detection and management. Cardiovascular diseases must be evaluated with priority. The initial evaluation should include a thorough examination to prevent the deleterious effect of comorbidities in RA.
- Published
- 2017
- Full Text
- View/download PDF
24. Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.
- Author
-
Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Serna-Peña G, Arvizu-Rivera RI, Martinez-Moreno A, Wah-Suarez M, and Garza Elizondo MA
- Subjects
- Aged, Arthritis, Rheumatoid epidemiology, Cardiovascular Diseases epidemiology, Cross-Sectional Studies, Female, Humans, Male, Mexico epidemiology, Middle Aged, Risk Assessment methods, Arthritis, Rheumatoid complications, Cardiovascular Diseases etiology
- Abstract
Variability of the 10-year cardiovascular (CV) risk predicted by the Framingham Risk Score (FRS) using lipids, FRS using body mass index (BMI), Reynolds Risk Score (RRS), QRISK2, Extended Risk Score-Rheumatoid Arthritis (ERS-RA), and algorithm developed by the American College of Cardiology and the American Heart Association in 2013 (ACC/AHA 2013) according to the European League Against Rheumatism (EULAR) 2015/2016 update of its evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis (RA) has not been evaluated in Mexican mestizo patients. CV risk was predicted using six different risk calculators in 116 patients, aged 40-75, who fulfilled the ACR/EULAR 2010 classification criteria. Results were multiplied by 1.5 according to the EULAR 2015/2016 update. Global comparison of the risk predicted by all scales was done using the Friedman test, considering a P value of ≤0.05 as statistically significant. Individual comparison between the algorithms was made using the Wilcoxon signed-rank test, and a P value of ≤0.003 was considered statistically significant. All calculators showed to be different in the Friedman test (p ≤ 0.001). Median values of predicted 10-year CV risk were 11.02% (6.18-17.55) for FRS BMI; 8.47% (4.6-13.16) for FRS lipids; 5.55% (2.5-11.85) for QRISK2; 5% (3.1-8.65) for ERS-RA; 3.6% (1.5-9.3) for ACC/AHA 2013; and 1.5% (1.5-4.5) for RRS. ERS-RA showed no difference when compared against QRISK2 (p = 0.269). CV risk calculators showed variability among them and cannot be used indistinctly in RA-patients.
- Published
- 2017
- Full Text
- View/download PDF
25. Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis.
- Author
-
Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, Garcia-Colunga JI, Arvizu-Rivera RI, Martinez-Moreno A, Villarreal-Perez JZ, Elizondo-Riojas G, and Garza Elizondo MA
- Subjects
- Aged, Atherosclerosis blood, Atherosclerosis complications, Atherosclerosis diagnostic imaging, Carotid Artery Diseases blood, Carotid Artery Diseases complications, Carotid Artery Diseases diagnostic imaging, Cross-Sectional Studies, Female, Humans, Male, Mexico, Middle Aged, Plaque, Atherosclerotic blood, Plaque, Atherosclerotic complications, Plaque, Atherosclerotic diagnostic imaging, Risk Assessment, Ultrasonography, Arthritis, Rheumatoid complications, Atherosclerosis drug therapy, Carotid Artery Diseases drug therapy, Cholesterol blood, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Plaque, Atherosclerotic drug therapy
- Abstract
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in rheumatoid arthritis (RA) patients. Guidelines of the American College of Cardiology and the American Heart Association (ACC/AHA) 2013 and the Adult Treatment Panel III (ATP-III) differ in their strategies to recommend initiation of statin therapy. The presence of carotid plaque (CP) by carotid ultrasound is an indication to begin statin therapy. We aimed to compare the recommendation to initiate statin therapy according to the ACC/AHA 2013 guidelines, ATP-III guidelines, and CP by carotid ultrasound. We then carried out an observational, cross-sectional study of 62 statin-naive Mexican mestizo RA patients, aged 40 to 75, who fulfilled the 1987 or 2010 ACR/European League Against Rheumatism (EULAR) classification criteria. CP was evaluated with B-mode ultrasound. Cohen's kappa (k) was used to assess agreement between ACC/AHA 2013 guidelines, ATP-III guidelines, and the presence of CP, considering a p < 0.05 as statistically significant. Agreement was classified as slight (0.01-0.20), fair (0.21-0.40), moderate (0.41-0.60), substantial (0.61-0.80), and an almost perfect agreement (0.81-1.00). Slight agreement (k = 0.096) was found when comparing statin recommendation between CP and ATP-III. Fair agreement (k = 0.242) was revealed between ACC/AHA 2013 and ATP-III. Comparison between ACC/AHA 2013 and CP showed moderate agreement (k = 0.438). ACC/AHA 2013 guidelines could be an adequate and cost-effective tool to evaluate the need of statin therapy in Mexican mestizo RA patients, with moderate agreement with the presence of CP by ultrasound.
- Published
- 2016
- Full Text
- View/download PDF
26. Evaluation of left ventricular function using volumetric computed tomography in the clinical setting.
- Author
-
de la Peña-Almaguer E, Trevino AR, Sierra-Galan L, Azpiri-Lopez JR, Assad-Morell JL, Kirsch J, and Chang SM
- Subjects
- Female, Heart Function Tests methods, Humans, Male, Middle Aged, Cone-Beam Computed Tomography, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease physiopathology, Magnetic Resonance Imaging, Ventricular Function, Left physiology
- Abstract
Objective: To correlate the left ventricular parameters obtained with 64-slice Volumetric Computed Tomography (VCT) with those obtained with the reference standard, cardiovascular magnetic resonance (CMR) imaging., Methods: VCT and a 3.0T MRI scanner were used. Results from both studies were independently evaluated by two cardiologists. A linear correlation and a paired Student's t test were used to analyze the data with a P<0.05 being considered significant., Results: Thirty consecutive patients were evaluated with VCT and CMR. The left ventricular indices for CMR and VCT were, respectively, mass 86.4±25.8 vs. 82.7±27.6g (P=0.31); ESV 45.5±27.8 vs. 48.7±40.4ml (P=.405); EDV 101.3±32.7 vs. 105.1±44.0ml (P=0.475); SV 55.9±16.1 vs. 56.8±15.6ml (P=0.713); LVEF 57.5±13.2% vs. 56.9±12.4% (P=0.630). No differences in intraobserver variability for both methods were found, CT r=0.96, r(2)=0.92 P<0.0001 and MR r=0.96 r(2)=0.93 P<0.0001. There was no significant statistical difference in the presence of artifacts., Conclusion: There is a close correlation between CMRI and VCT in the evaluation of LV function. VCT is as useful as 3T CMR, and could be incorporated as another resource for evaluating LV function., (Copyright © 2015 Instituto Nacional de Cardiología Ignacio Chávez. Published by Masson Doyma México S.A. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
27. Safety and Clinical Outcome of the Delivery of Radiofrequency Nerve Ablation Therapy in a Renal Artery of Unusual Anatomy.
- Author
-
de Leon-Martinez EP, Garza JA, Azpiri-Lopez JR, Dillon KN, Salazar LO, Canepa-Campos F, Rousselle SD, and Tellez A
- Subjects
- Antihypertensive Agents therapeutic use, Drug Resistance, Humans, Hypertension diagnosis, Hypertension physiopathology, Male, Middle Aged, Renal Artery diagnostic imaging, Renal Artery innervation, Tomography, X-Ray Computed, Treatment Outcome, Blood Pressure drug effects, Catheter Ablation, Hypertension surgery, Kidney blood supply, Renal Artery abnormalities, Renal Artery surgery, Sympathectomy methods
- Abstract
Introduction: Catheter-based renal sympathetic denervation is an emerging therapy for resistant hypertension (RHTN) patients, resulting in a significant blood pressure reduction. The presence of accessory renal arteries and anomalous branching patterns are reported in approximately 20-27 % of patients. However, accessory renal arteries, when smaller than 4 mm in diameter, they are out of the inclusion criteria for renal denervation therapy. For this reason patients with evidence of accessory renal arteries have been excluded in previous clinical trials. Recent data suggest that accessory renal arteries may play an important role in non-response therapy when they do not receive renal denervation treatment., Case Report: In this report, we present the outcome of a patient with resistant hypertension and an anomalous right renal artery, having undergone denervation of both principal and accessory renal arteries. The renal ablation by radiofrequency energy of a distant accessory renal artery resulted in a safe procedure with no clinical complications., Conclusion: Consistent with literature the RDN of all, main and accessory renal arteries, was effective in decreasing patient blood pressure while decreasing the need for antihypertensive medication.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.